APA (7th ed.) Citation

T, W., M, P., K, A., DM, G., M, M., M, D., . . . R, H. (2024). Real-world effectiveness of first- and second-line anti-angiogenesis therapy in RCC: Analysis of a UK-based population. Future oncology (London, England), 20(33), 2547. https://doi.org/10.1080/14796694.2024.2385882

Chicago Style (17th ed.) Citation

T, Waddell, Pillai M, Armitage K, Graham DM, Moran M, Dilleen M, Holmes S, Śleszyńska-Dopiera E, and Hawkins R. "Real-world Effectiveness of First- and Second-line Anti-angiogenesis Therapy in RCC: Analysis of a UK-based Population." Future Oncology (London, England) 20, no. 33 (2024): 2547. https://doi.org/10.1080/14796694.2024.2385882.

MLA (9th ed.) Citation

T, Waddell, et al. "Real-world Effectiveness of First- and Second-line Anti-angiogenesis Therapy in RCC: Analysis of a UK-based Population." Future Oncology (London, England), vol. 20, no. 33, 2024, p. 2547, https://doi.org/10.1080/14796694.2024.2385882.